About

Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company. In Q3, 2017, Armetheon merged with Espero Pharmaceuticals, Inc to become Espero BioPharma, Inc, a commercial-stage cardiovascular-focused company with 3 marketed products and a potential blockbuster pipeline. [www.esperobio.com]

Tags : #Pharmaceuticals, #DrugDevelopment, #Anticoagulants, #Cardiovascular, #ResearchDevelopment

Location :
3375 Scott Blvd, Santa Clara, California 95054-3103

Gallery